Further investigation to decipher microenvironmental cues favoring FN1-integrin pathways are needed to identify key signaling components that participate to dormant cell reactivation, offering new targets and therapeutic agents to fight metastatic disease. The gene discussed is FN1; the disease is metastatic neoplasm.